Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and rhein

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with rhein in 1 studies

Compound Research Comparison

Studies
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)
Trials
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)
Recent Studies (post-2010)
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)
Studies
(rhein)
Trials
(rhein)
Recent Studies (post-2010) (rhein)
80216207368

Protein Interaction Comparison

ProteinTaxonomyn,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine (IC50)rhein (IC50)
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)3.3393
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)3.3393
tyrosine-protein phosphatase non-receptor type 7 isoform 2Homo sapiens (human)19.62

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, Y; Gong, T; Jiang, J; Li, J; Sun, X; Zhang, J; Zhang, Z1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and rhein

ArticleYear
Dual pancreas- and lung-targeting therapy for local and systemic complications of acute pancreatitis mediated by a phenolic propanediamine moiety.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Aug-28, Volume: 212

    Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Cell Line; Cell Survival; HeLa Cells; Hep G2 Cells; Humans; Interleukin-6; Iodobenzenes; Lung; Male; Pancreas; Pancreatitis; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2015